161 related articles for article (PubMed ID: 25656574)
1. PSMB4 promotes multiple myeloma cell growth by activating NF-κB-miR-21 signaling.
Zheng P; Guo H; Li G; Han S; Luo F; Liu Y
Biochem Biophys Res Commun; 2015 Mar; 458(2):328-33. PubMed ID: 25656574
[TBL] [Abstract][Full Text] [Related]
2. PSMB4 expression associates with epithelial ovarian cancer growth and poor prognosis.
Liu R; Lu S; Deng Y; Yang S; He S; Cai J; Qiang F; Chen C; Zhang W; Zhao S; Qian L; Mao G; Wang Y
Arch Gynecol Obstet; 2016 Jun; 293(6):1297-307. PubMed ID: 26439929
[TBL] [Abstract][Full Text] [Related]
3. Knockdown of REGγ inhibits the proliferation and migration and promotes the apoptosis of multiple myeloma cells by downregulating NF-κB signal pathway.
Liu S; Zheng LL; Zhu YM; Shen HJ; Zhong Q; Huang J; Li C; Liu Z; Yao MD; Ou RM; Zhang Q
Hematology; 2018 Jun; 23(5):277-283. PubMed ID: 29020881
[TBL] [Abstract][Full Text] [Related]
4. PCAT-1 promotes cell growth by sponging miR-129 via MAP3K7/NF-κB pathway in multiple myeloma.
Shen X; Kong S; Yang Q; Yin Q; Cong H; Wang X; Ju S
J Cell Mol Med; 2020 Mar; 24(6):3492-3503. PubMed ID: 32048803
[TBL] [Abstract][Full Text] [Related]
5. PSMB4 overexpression enhances the cell growth and viability of breast cancer cells leading to a poor prognosis.
Wang H; He Z; Xia L; Zhang W; Xu L; Yue X; Ru X; Xu Y
Oncol Rep; 2018 Oct; 40(4):2343-2352. PubMed ID: 30066880
[TBL] [Abstract][Full Text] [Related]
6. PSMB4 inhibits cardiomyocyte apoptosis via activating NF-κB signaling pathway during myocardial ischemia/reperfusion injury.
Yang C; Yu P; Yang F; He Q; Jiang B; Zheng L; Wang Q; Wang J; Qiu H; Wang H; Zhang L
J Mol Histol; 2021 Aug; 52(4):693-703. PubMed ID: 33954843
[TBL] [Abstract][Full Text] [Related]
7. Reduced microRNA-218 expression is associated with high nuclear factor kappa B activation in gastric cancer.
Gao C; Zhang Z; Liu W; Xiao S; Gu W; Lu H
Cancer; 2010 Jan; 116(1):41-9. PubMed ID: 19890957
[TBL] [Abstract][Full Text] [Related]
8. MiR-9 promotes multiple myeloma progression by regulating TRIM56/NF-κB pathway.
Huang G; Liu X; Zhao X; Zhao J; Hao J; Ren J; Chen Y
Cell Biol Int; 2019 Nov; 43(11):1223-1233. PubMed ID: 30637864
[TBL] [Abstract][Full Text] [Related]
9. MicroRNA-1271 inhibits proliferation and promotes apoptosis of multiple myeloma cells through inhibiting smoothened-mediated Hedgehog signaling pathway.
Xu Z; Huang C; Hao D
Oncol Rep; 2017 Feb; 37(2):1261-1269. PubMed ID: 27959416
[TBL] [Abstract][Full Text] [Related]
10. NF-κB targets miR-16 and miR-21 in gastric cancer: involvement of prostaglandin E receptors.
Shin VY; Jin H; Ng EK; Cheng AS; Chong WW; Wong CY; Leung WK; Sung JJ; Chu KM
Carcinogenesis; 2011 Feb; 32(2):240-5. PubMed ID: 21081469
[TBL] [Abstract][Full Text] [Related]
11. Downregulation of miR-138 sustains NF-κB activation and promotes lipid raft formation in esophageal squamous cell carcinoma.
Gong H; Song L; Lin C; Liu A; Lin X; Wu J; Li M; Li J
Clin Cancer Res; 2013 Mar; 19(5):1083-93. PubMed ID: 23319823
[TBL] [Abstract][Full Text] [Related]
12. Canonical nuclear factor kappaB pathway inhibition blocks myeloma cell growth and induces apoptosis in strong synergy with TRAIL.
Romagnoli M; Desplanques G; Maïga S; Legouill S; Dreano M; Bataille R; Barillé-Nion S
Clin Cancer Res; 2007 Oct; 13(20):6010-8. PubMed ID: 17947462
[TBL] [Abstract][Full Text] [Related]
13. SENP1 inhibition induces apoptosis and growth arrest of multiple myeloma cells through modulation of NF-κB signaling.
Xu J; Sun HY; Xiao FJ; Wang H; Yang Y; Wang L; Gao CJ; Guo ZK; Wu CT; Wang LS
Biochem Biophys Res Commun; 2015 May; 460(2):409-15. PubMed ID: 25791478
[TBL] [Abstract][Full Text] [Related]
14. MicroRNA-520e suppresses growth of hepatoma cells by targeting the NF-κB-inducing kinase (NIK).
Zhang S; Shan C; Kong G; Du Y; Ye L; Zhang X
Oncogene; 2012 Aug; 31(31):3607-20. PubMed ID: 22105365
[TBL] [Abstract][Full Text] [Related]
15. Hepatitis C virus-induced up-regulation of microRNA-155 promotes hepatocarcinogenesis by activating Wnt signaling.
Zhang Y; Wei W; Cheng N; Wang K; Li B; Jiang X; Sun S
Hepatology; 2012 Nov; 56(5):1631-40. PubMed ID: 22610915
[TBL] [Abstract][Full Text] [Related]
16. Identification of novel miR-21 target proteins in multiple myeloma cells by quantitative proteomics.
Xiong Q; Zhong Q; Zhang J; Yang M; Li C; Zheng P; Bi LJ; Ge F
J Proteome Res; 2012 Apr; 11(4):2078-90. PubMed ID: 22316494
[TBL] [Abstract][Full Text] [Related]
17. [Effect of miR-202 on the growth of multiple myeloma cells via regulating B cell-activating factor and the underlying mechanism].
Yu JJ; Shen XJ; Wang XD; Ju SQ
Zhonghua Zhong Liu Za Zhi; 2013 Dec; 35(12):886-91. PubMed ID: 24506956
[TBL] [Abstract][Full Text] [Related]
18. Genome-wide screening reveals that miR-195 targets the TNF-α/NF-κB pathway by down-regulating IκB kinase alpha and TAB3 in hepatocellular carcinoma.
Ding J; Huang S; Wang Y; Tian Q; Zha R; Shi H; Wang Q; Ge C; Chen T; Zhao Y; Liang L; Li J; He X
Hepatology; 2013 Aug; 58(2):654-66. PubMed ID: 23487264
[TBL] [Abstract][Full Text] [Related]
19. Regulation of miRNA-21 by reactive oxygen species-activated ERK/NF-κB in arsenite-induced cell transformation.
Ling M; Li Y; Xu Y; Pang Y; Shen L; Jiang R; Zhao Y; Yang X; Zhang J; Zhou J; Wang X; Liu Q
Free Radic Biol Med; 2012 May; 52(9):1508-18. PubMed ID: 22387281
[TBL] [Abstract][Full Text] [Related]
20. A p53-dependent tumor suppressor network is induced by selective miR-125a-5p inhibition in multiple myeloma cells.
Leotta M; Biamonte L; Raimondi L; Ronchetti D; Di Martino MT; Botta C; Leone E; Pitari MR; Neri A; Giordano A; Tagliaferri P; Tassone P; Amodio N
J Cell Physiol; 2014 Dec; 229(12):2106-16. PubMed ID: 24819167
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
